In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, discuss notable new meds of 2024.

Listen in as our editors discuss several novel drugs approved in 2024...and highlight some medications now available in a new dosage form. They’ll review efficacy, safety, and considerations for use with these new treatment options.

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• On Demand Webinar: Notable New Meds of 2024
• Articles:
  • Clarify the Role of Sofpironium for Hyperhidrosis
  • Watch for Ensifentrine for COPD
  • Don’t Rush to Aprocitentan for Resistant Hypertension
  • New Drug for Schizophrenia Targets Muscarinic Receptors
  • Be Familiar With Carbidopa/Levodopa Options
• New Drug Overviews:
  • Aprocitentan (Tryvio)
  • Epinephrine Nasal Spray (Neffy)
  • Xanomeline/Trospium (

Check out our NEW podcasts.

Rumor vs Truth
Your trusted source for facts... where we dissect the evidence behind risky rumors and reveal clinical truths.

Clinical Capsules
TRC editors break down the most impactful clinical developments - giving you clear, actionable takeaways in just minutes.

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

In this episode, TRC Healthcare editors, Sara Klockars, PharmD, BCPS, and Stephen Small, PharmD, BCPS, BCPPS, BCCCP, CNSC, tackle the topic of Natural Medicines.

Listen in as they define what natural medicines are... and discuss the safety and efficacy of several natural medicines, including ashwagandha, berberine, and turmeric. They’ll also discuss how to navigate discussions with patients about supplements, including tips for choosing a quality supplement.

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

You can find more about these topics with resources that are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Be Prepared With Guidance About Ashwagandha
• Article: Don’t Recommend Berberine as a GLP-1 Agonist Alternative
• Article: Give Guidance About Coenzyme Q10
• Article: Clarify the Effectiveness and Safety of Melatonin
• Article: Be Prepared With Advice About Turmeric

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.

Special guest Jean-Venable “Kelly” R. Goode, PharmD, BCPS, FAPhA, FCCP, Professor and Director of the Community-Based Residency Program at the Virginia Commonwealth University School of Pharmacy, join(s) us to talk about immunizations.

Listen in as we discuss the latest COVID-19, influenza, and RSV vaccine recommendations and answer some common questions about giving vaccines.

You’ll also hear practical advice from TRC Editorial Advisory Board member, Stephen Carek, MD, CAQSM, DipABLM, the Program Director for the Prisma Health/USC School of Medicine Greenville Family Medicine Residency Program and Clinical Associate Professor at the University of South Carolina School of Medicine, Greenville.

For the purposes of disclosure, Dr. Goode reports relevant financial relationships [vaccines] with Pfizer, Valneva (honorarium). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.

TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist’s Letter, Pharmacy Technician’s Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.

Claim Credit

The clinical resources mentioned during the podcast are part of a subscription to Pharmacist’s Letter and Prescriber Insights:

• Chart: Flu Vaccines for 2024-25 (United States)
• Chart: COVID-19 Vaccines 2024-25 (United States)
• FAQ: Preventing RSV
• Resource Hub: Immunization Resource Hub

If you’re not yet a subscriber, find out more about our product offerings at trchealthcare.com.

Follow, rate, and review this show in your favorite podcast app. Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com.